ANCY THOMAS: Open Payments
NPI 1952877409 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,100 in 101 payments from 36 companies in 2025. Trend: 2023 $690 · 2024 $2,083 · 2025 $2,100
Food & beverage: $2,100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $303 |
| Daiichi Sankyo Inc. | 13 | $226 |
| Merck Sharp & Dohme LLC | 9 | $148 |
| ABBVIE INC. | 4 | $106 |
| JAZZ PHARMACEUTICALS INC. | 4 | $97 |
| Regeneron Healthcare Solutions, Inc. | 4 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $76 |
| Geron Corporation | 3 | $69 |
| Incyte Corporation | 3 | $69 |
| Eisai Inc. | 3 | $65 |
Products named: Enhertu, KEYTRUDA, RYBREVANT, ZEPZELCA, EPKINLY, ERLEADA, FRUZAQLA, RYTELO.
Industry payments across TX — which companies pay providers there.
